321 related articles for article (PubMed ID: 15581379)
1. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
Maples KR; Green AR; Floyd RA
CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
[TBL] [Abstract][Full Text] [Related]
2. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
Green AR; Ashwood T; Odergren T; Jackson DM
Pharmacol Ther; 2003 Dec; 100(3):195-214. PubMed ID: 14652110
[TBL] [Abstract][Full Text] [Related]
3. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
Green AR; Ashwood T
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
[TBL] [Abstract][Full Text] [Related]
4. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke.
Lapchak PA; Araujo DM
CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797
[TBL] [Abstract][Full Text] [Related]
5. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions.
Dehouck MP; Cecchelli R; Richard Green A; Renftel M; Lundquist S
Brain Res; 2002 Nov; 955(1-2):229-35. PubMed ID: 12419541
[TBL] [Abstract][Full Text] [Related]
6. NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
Han M; He QP; Yong G; Siesjö BK; Li PA
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1249-52. PubMed ID: 14983994
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.
Kuroda S; Tsuchidate R; Smith ML; Maples KR; Siesjö BK
J Cereb Blood Flow Metab; 1999 Jul; 19(7):778-87. PubMed ID: 10413033
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
10. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
11. NXY-059: a neuroprotective agent in acute stroke.
Wang CX; Shuaib A
Int J Clin Pract; 2004 Oct; 58(10):964-9. PubMed ID: 15587776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2005 Dec; 26(6):969-79. PubMed ID: 15890407
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
[TBL] [Abstract][Full Text] [Related]
14. NXY-059: review of neuroprotective potential for acute stroke.
Fong JJ; Rhoney DH
Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
[TBL] [Abstract][Full Text] [Related]
15. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.
Marshall JW; Cummings RM; Bowes LJ; Ridley RM; Green AR
Stroke; 2003 Sep; 34(9):2228-33. PubMed ID: 12920263
[TBL] [Abstract][Full Text] [Related]
16. NXY-059. Centaur.
Lapchak PA
Curr Opin Investig Drugs; 2002 Dec; 3(12):1758-62. PubMed ID: 12528313
[TBL] [Abstract][Full Text] [Related]
17. In vivo neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176).
Lockhart B; Roger A; Bonhomme N; Goldstein S; Lestage P
Eur J Pharmacol; 2005 Mar; 511(2-3):127-36. PubMed ID: 15792780
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats.
Gray C; Nukada H; Jackson DM; McMorran PD; Wu A; Ma F
Brain Res; 2003 Aug; 982(2):179-85. PubMed ID: 12915253
[TBL] [Abstract][Full Text] [Related]
19. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
[TBL] [Abstract][Full Text] [Related]
20. NXY 059: CPI 22, NXY 059G.
Adis International Ltd
Drugs R D; 2003; 4(4):254-7. PubMed ID: 12848592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
